Amylyx Pharmaceuticals Logo

Amylyx Pharmaceuticals

🇺🇸
AMLX
US03237H1014

Amylyx Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative treatments for neurodegenerative diseases, such as ALS. Through rigorous scientific research and targeted therapies, Amylyx works to make a lasting, meaningful impact on patients' lives.

Next Quarterly Earnings

Thursday, November 5, 2026
CW 45
Pre-Market
In 70 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Quiet period starts on October 8, 2026

Stock Price

Frequently asked questions

When will Amylyx Pharmaceuticals report its next quarterly earnings?

Amylyx Pharmaceuticals is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did Amylyx Pharmaceuticals last report quarterly earnings?

Amylyx Pharmaceuticals last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.39 USD.

How does Amylyx Pharmaceuticals stock react to earnings?

Across its last 3 earnings reports, Amylyx Pharmaceuticals stock moved by ±7.9% on average the following day. The largest reaction was +10.7% on 08/06/2026; 1 of 3 reactions were positive.

How often has Amylyx Pharmaceuticals beaten expectations?

Amylyx Pharmaceuticals has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).

How do I add the Amylyx Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.38
Actual:
Q2 2026
Missed
Estimate:-$0.36
Actual:-$0.39
Difference:-$0.03
Price reaction (1 day):+10.7 %
Price reaction (7 days):+2.9 %
Q1 2026
Missed
Estimate:-$0.34
Actual:-$0.37
Difference:-$0.03
Price reaction (1 day):-5.4 %
Price reaction (7 days):-13.6 %
Q4 2025
Beat
Estimate:-$0.35
Actual:-$0.30
Difference:+$0.05
Price reaction (1 day):-7.8 %
Price reaction (7 days):-2.1 %
Q2 2025
Beat
Estimate:-$0.43
Actual:-$0.37
Difference:+$0.06
Q1 2025
Missed
Estimate:-$0.45
Actual:-$0.46
Difference:-$0.01

Earnings statistics

Stock reaction to earnings

±7.9%
Avg. next-day move
+10.7%
Largest move (08/06/2026)
33.3%
Share of positive reactions
±6.2%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Estimates vs. results

2/5
Quarters above estimates
40%
Beat rate
-0.5%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Amylyx Pharmaceuticals
Ticker Symbol
AMLX
ISIN
US03237H1014
Country
🇺🇸
USA
Sector